Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics

By: via Benzinga
Baxter International Inc. (NYSE: BAX) today announced that it has entered into a definitive agreement to sell its proprietary Vero cell ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.